The Promise of Telemedicine for Movement Disorders: an Interdisciplinary Approach

  • H. Ben-Pazi
  • P. Browne
  • P. Chan
  • E. Cubo
  • M. Guttman
  • A. Hassan
  • J. Hatcher-Martin
  • Z. Mari
  • E. Moukheiber
  • N. U. Okubadejo
  • A. Shalash
  • the International Parkinson and Movement Disorder Society Telemedicine Task Force
Movement Disorders (S Fox, Section Editor)
Part of the following topical collections:
  1. Topical Collection on Movement Disorders


Purpose of Review

Advances in technology have expanded telemedicine opportunities covering medical practice, research, and education. This is of particular importance in movement disorders (MDs), where the combination of disease progression, mobility limitations, and the sparse distribution of MD specialists increase the difficulty to access. In this review, we discuss the prospects, challenges, and strategies for telemedicine in MDs.

Recent Findings

Telemedicine for MDs has been mainly evaluated in Parkinson’s disease (PD) and compared to in-office care is cost-effective with similar clinical care, despite the barriers to engagement. However, particular groups including pediatric patients, rare MDs, and the use of telemedicine in underserved areas need further research.


Interdisciplinary telemedicine and tele-education for MDs are feasible, provide similar care, and reduce travel costs and travel time compared to in-person visits. These benefits have been mainly demonstrated for PD but serve as a model for further validation in other movement disorders.


Telemedicine Movement disorders Telehealth Tele-education 



To Drew Whalen for editorial assistance.

Telemedicine task Force Members of the International Parkinson´s disease and Movement Disorders Society

1. Bajwa J, Director, Parkinson´s, Movement Disorders and Neurorestoration National Neuroscience Institute King Fahad Medical City Riyadh, Saudi Arabia

2. Bloem BR, Radboud university medical center; Donders Institute for Brain, Cognition and Behaviour; Department of Neurology; Nijmegen, the Netherlands.

3. Galifianakis NB, Department of Neurology, University of California, San Francisco, San Francisco, California, USA.

4. Gatto E, Instituto de Neurociencias Buenos Aires, INEBA, Buenos Aires, Argentina.

5. Goetz CG, Rush University Medical Center, Chicago, IL, USA.

6. Katz M, Neurology, University of California San Francisco, San Francisco, Calif., USA.

7. Pantelyat A, Department of Neurology, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA

8. Tanner C, Parkinson's Disease Research, Education and Clinical Center, Neurology, San Francisco Veterans Affairs Medical Center, San Francisco, California, USA. Department of Neurology, University of California-San Francisco, San Francisco, California, USA.

9. Spindler M, Department of Neurology, University of Pennsylvania Perelman School of Medicine, Philadelphia, PA, USA

Compliance with Ethics Standards

Conflict of Interest

Browne P, Chan P, Cubo E, Guttman M, Hassan A, Hatcher JM, Moukheiber E, Okubadejo NU, Shalash A, Bajwa J, Bloem BR, Galifianakis N, Gatto E, Goetz CG, Katz M, Mari Z, Pantelyat A, Tanner C, and Spindler M declare that they have no conflict of interest.

Ben-Pazi H is the founder of NeuroCan LTD, providing accessible neurological services including teleNeurology clinics.

Human and Animal Rights and Informed Consent

This article does not contain any studies with human or animal subjects performed by any of the authors.


Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance

  1. 1.
    Institute of Medicine (US) Committee on Evaluating Clinical Applications of Telemedicine; Field MJ, editor. Telemedicine: a guide to assessing telecommunications in health care. Washington (DC): National Academies Press (US); 1996.Google Scholar
  2. 2.
    World Health Organization. Telemedicine: opportunities and developments in member states: report on the second global survey on eHealth 2009. Global Observatory for eHealth Series; 2010. pp. 2.Google Scholar
  3. 3.
    Cubo E, Doumbe J, Lopez E, et al. Telemedicine enables broader access to movement disorders curricula for medical students. Tremor Other Hyperkinet Mov (N Y). 2017;7:501.Google Scholar
  4. 4.
    Evolution and Current Applications of Telemedicine. Available from
  5. 5.
    •• Achey M, Aldred JL, Aljehani N, et al. The past, present, and future of telemedicine for Parkinson’s disease. Mov Disord. 2014;29:871–83. This article reports the past, present, and likely future applications of telemedicine to Parkinson’s disease.CrossRefPubMedGoogle Scholar
  6. 6.
    Dorsey ER, Vlaanderen FP, Engelen LJ, et al. Moving Parkinson care to the home. Mov Disord. 2016;31:1258–62.CrossRefPubMedPubMedCentralGoogle Scholar
  7. 7.
    Speedie SM, Ferguson AS, Sanders J, Doarn CR. Telehealth: the promise of new care delivery models. Telemed J E Health. 2008;14:964–7.CrossRefPubMedGoogle Scholar
  8. 8.
    Wechsler LR, Tsao JW, Levine SR, et al. Teleneurology applications: report of the telemedicine work Group of the American Academy of Neurology. Neurology. 2013;80:670–6.CrossRefPubMedPubMedCentralGoogle Scholar
  9. 9.
    •• Schneider RB, Biglan KM. The promise of telemedicine for chronic neurological disorders: the example of Parkinson’s disease. Lancet Neurol. 2017;16:541–51. This article describes the benefits of telemedicine for Parkinson’s disease and limitations and barriers to widespread implementation of telemedicine services remain to be addressed, including reimbursement, legal considerations, and technological issues.CrossRefPubMedGoogle Scholar
  10. 10.
    Velasquez SE, Chaves-Carballo E, Nelson EL. Pediatric Teleneurology: a model of epilepsy care for rural populations. Pediatr Neurol. 2016;64:32–7.CrossRefPubMedGoogle Scholar
  11. 11.
    Hubble JP. Interactive video conferencing and Parkinson’s disease. Kans Med. 1992;93:351–2.PubMedGoogle Scholar
  12. 12.
    Goetz CG, Stebbins GT, Wolff D, DeLeeuw W, Bronte-Stewart H, Elble R, et al. Testing objective measures of motor impairment in early Parkinson’s disease: feasibility study of an at-home testing device. Mov Disord. 2009;24:551–6.CrossRefPubMedPubMedCentralGoogle Scholar
  13. 13.
    Cubo E, Gabriel-Galan JM, Martinez JS, et al. Comparison of office-based versus home web-based clinical assessments for Parkinson's disease. Mov Disord. 2012;27:308–11.CrossRefPubMedGoogle Scholar
  14. 14.
    Dorsey ER, Deuel LM, Voss TS, Finnigan K, George BP, Eason S, et al. Increasing access to specialty care: a pilot, randomized controlled trial of telemedicine for Parkinson's disease. Mov Disord. 2010;25:1652–9.CrossRefPubMedGoogle Scholar
  15. 15.
    Dorsey ER, Venkataraman V, Grana MJ, Bull MT, George BP, Boyd CM, et al. Randomized controlled clinical trial of “virtual house calls” for Parkinson disease. JAMA Neurol. 2013;70:565–70.CrossRefPubMedPubMedCentralGoogle Scholar
  16. 16.
    Abdolahi A, Scoglio N, Killoran A, Dorsey ER, Biglan KM. Potential reliability and validity of a modified version of the unified Parkinson’s disease rating scale that could be administered remotely. Parkinsonism Relat Disord. 2013;19:218–21.CrossRefPubMedGoogle Scholar
  17. 17.
    Dorsey ER, Bloem BR. The Parkinson pandemic-a call to action. JAMA Neurol. 2018;75:9–10.CrossRefPubMedGoogle Scholar
  18. 18.
    Dall TM, Storm MV, Chakrabarti R, Drogan O, Keran CM, Donofrio PD, et al. Supply and demand analysis of the current and future US neurology workforce. Neurology. 2013;81:470–8.CrossRefPubMedPubMedCentralGoogle Scholar
  19. 19.
    Cheng EM, Swarztrauber K, Siderowf AD, Eisa MS, Lee M, Vassar S, et al. Association of specialist involvement and quality of care for Parkinson’s disease. Mov Disord. 2007;22:515–22.CrossRefPubMedGoogle Scholar
  20. 20.
    Dorsey ER, Voss TS, Shprecher DR, Deuel LM, Beck CA, Gardiner IF, et al. A U.S. survey of patients with Parkinson’s disease: satisfaction with medical care and support groups. Mov Disord. 2010;25:2128–35.CrossRefPubMedGoogle Scholar
  21. 21.
    Burke JF, Albin RL. Do neurologists make a difference in Parkinson disease care? Neurology. 2011;77:e52–3.CrossRefPubMedGoogle Scholar
  22. 22.
    Bull MT, Darwin K, Venkataraman V, Wagner J, Beck CA, Dorsey ER, et al. A pilot study of virtual visits in Huntington disease. J Huntingtons Dis. 2014;3:189–95.PubMedGoogle Scholar
  23. 23.
    Hawkins AK, Creighton S, Ho A, McManus B, Hayden MR. Providing predictive testing for Huntington disease via telehealth: results of a pilot study in British Columbia, Canada. Clin Genet. 2013;84:60–4.CrossRefPubMedGoogle Scholar
  24. 24.
    Amarendran V, George A, Gersappe V, Krishnaswamy S, Warren C. The reliability of telepsychiatry for a neuropsychiatric assessment. Telemed J E Health. 2011;17:223–5.CrossRefPubMedGoogle Scholar
  25. 25.
    Martino D, Ganos C, Pringsheim TM. Tourette syndrome and chronic tic disorders: the clinical spectrum beyond tics. Int Rev Neurobiol. 2017;134:1461–90.CrossRefPubMedGoogle Scholar
  26. 26.
    Goetz CG, Leurgans S, Chmura TA. Home alone: methods to maximize tic expression for objective videotape assessments in Gilles de la Tourette syndrome. Mov Disord. 2001;16:693–7.CrossRefPubMedGoogle Scholar
  27. 27.
    Piacentini J, Woods DW, Scahill L, Wilhelm S, Peterson AL, Chang S, et al. Behavior therapy for children with Tourette disorder: a randomized controlled trial. JAMA. 2010;303:1929–37.CrossRefPubMedPubMedCentralGoogle Scholar
  28. 28.
    Wilhelm S, Peterson AL, Piacentini J, Woods DW, Deckersbach T, Sukhodolsky DG, et al. Randomized trial of behavior therapy for adults with Tourette syndrome. Arch Gen Psychiatry. 2012;69:795–803.CrossRefPubMedPubMedCentralGoogle Scholar
  29. 29.
    Ricketts EJ, Goetz AR, Capriotti MR, Bauer CC, Brei NG, Himle MB, et al. A randomized waitlist-controlled pilot trial of voice over internet protocol-delivered behavior therapy for youth with chronic tic disorders. J Telemed Telecare. 2016;22:153–62.CrossRefPubMedGoogle Scholar
  30. 30.
    Conelea CA, Wellen BCM. Tic treatment goes tech: a review of Cogn Behav Pract. 2017;24:374–81.CrossRefPubMedGoogle Scholar
  31. 31.
    Foster MV, Sethares KA. Facilitators and barriers to the adoption of telehealth in older adults: an integrative review. Comput Inform Nurs. 2014;32:523–33. quiz 534-525CrossRefPubMedGoogle Scholar
  32. 32.
    Cialone J, Augustine EF, Newhouse N, Vierhile A, Marshall FJ, Mink JW. Quantitative telemedicine ratings in batten disease: implications for rare disease research. Neurology. 2011;77:1808–11.CrossRefPubMedPubMedCentralGoogle Scholar
  33. 33.
    Ragbeer SN, Augustine EF, Mink JW, Thatcher AR, Vierhile AE, Adams HR. Remote assessment of cognitive function in juvenile neuronal ceroid lipofuscinosis (batten disease): a pilot study of feasibility and reliability. J Child Neurol. 2016;31:481–7.CrossRefPubMedGoogle Scholar
  34. 34.
    Padela AI, Gunter K, Killawi A, Heisler M. Religious values and healthcare accommodations: voices from the American Muslim community. J Gen Intern Med. 2012;27:708–15.CrossRefPubMedPubMedCentralGoogle Scholar
  35. 35.
    Alajlani M, Clarke M. Effect of culture on acceptance of telemedicine in middle eastern countries: case study of Jordan and Syria. Telemed J E Health. 2013;19:305–11.CrossRefPubMedGoogle Scholar
  36. 36.
    U.S. Department of Veterans Affairs. FY 2018 / FY 2016: Annual performance plan and report [online]. Available at: Accessed 15 Nov 2017.
  37. 37.
  38. 38. Medicare Telehealth Parity Act of 2017. Available at: Accessed 4 Dec 2017.
  39. 39.
    Schneider R, Dorsey ER, Biglan K. Telemedicine Care for Nursing Home Residents with parkinsonism. J Am Geriatr Soc. 2016;64:218–20.CrossRefPubMedGoogle Scholar
  40. 40.
  41. 41.
    Li D, Zhang C, Gault J, Wang W, Liu J, Shao M, et al. Remotely programmed deep brain stimulation of the bilateral subthalamic nucleus for the treatment of primary Parkinson disease: a randomized controlled trial investigating the safety and efficacy of a novel deep brain stimulation system. Stereotact Funct Neurosurg. 2017;95:174–82.CrossRefPubMedGoogle Scholar
  42. 42.
    Pretzer-Aboff I, Prettyman A. Implementation of an integrative holistic healthcare model for people living with Parkinson’s disease. Gerontologist. 2015;55(Suppl 1):S146–53.CrossRefPubMedGoogle Scholar
  43. 43.
    Veenhuizen RB, Kootstra B, Vink W, Posthumus J, van Bekkum P, Zijlstra M, et al. Coordinated multidisciplinary care for ambulatory Huntington’s disease patients. Evaluation of 18 months of implementation. Orphanet J Rare Dis. 2011;6:77.CrossRefPubMedPubMedCentralGoogle Scholar
  44. 44.
    Veenhuizen RB, Tibben A. Coordinated multidisciplinary care for Huntington’s disease. An outpatient department. Brain Res Bull. 2009;80:192–5.CrossRefPubMedGoogle Scholar
  45. 45.
    Iacono T, Stagg K, Pearce N, Hulme Chambers A. A scoping review of Australian allied health research in ehealth. BMC Health Serv Res. 2016;16:543.CrossRefPubMedPubMedCentralGoogle Scholar
  46. 46.
    Van Allen J, Davis AM, Lassen S. The use of telemedicine in pediatric psychology: research review and current applications. Child Adolesc Psychiatr Clin N Am. 2011;20:55–66.CrossRefPubMedPubMedCentralGoogle Scholar
  47. 47.
    Wilson L, Onslow M, Lincoln M. Telehealth adaptation of the Lidcombe program of early stuttering intervention: five case studies. Am J Speech Lang Pathol. 2004;13:81–93.CrossRefPubMedGoogle Scholar
  48. 48.
    Lade H, McKenzie S, Steele L, Russell TG. Validity and reliability of the assessment and diagnosis of musculoskeletal elbow disorders using telerehabilitation. J Telemed Telecare. 2012;18:413–8.CrossRefPubMedGoogle Scholar
  49. 49.
    Crotty M, Killington M, van den Berg M, Morris C, Taylor A, Carati C. Telerehabilitation for older people using off-the-shelf applications: acceptability and feasibility. J Telemed Telecare. 2014;20:370–6.CrossRefPubMedGoogle Scholar
  50. 50.
    Bloem BR, de Vries NM, Ebersbach G. Nonpharmacological treatments for patients with Parkinson’s disease. Mov Disord. 2015;30:1504–20.CrossRefPubMedGoogle Scholar
  51. 51.
    Lee NY, Lee DK, Song HS. Effect of virtual reality dance exercise on the balance, activities of daily living, and depressive disorder status of Parkinson’s disease patients. J Phys Ther Sci. 2015;27:145–7.CrossRefPubMedPubMedCentralGoogle Scholar
  52. 52.
    Albiol-Perez S, Gil-Gomez JA, Munoz-Tomas MT, Gil-Gomez H, Vial-Escolano R, Lozano-Quilis JA. The effect of balance training on postural control in patients with Parkinson’s disease using a virtual rehabilitation system. Methods Inf Med. 2017;56:138–44.CrossRefPubMedGoogle Scholar
  53. 53.
    Canning CG, Sherrington C, Lord SR, Close JCT, Heritier S, Heller GZ, et al. Exercise for falls prevention in Parkinson disease: a randomized controlled trial. Neurology. 2015;84:304–12.CrossRefPubMedPubMedCentralGoogle Scholar
  54. 54.
    Siderowf A, Ravina B, Glick HA. Preference-based quality-of-life in patients with Parkinson's disease. Neurology. 2002;59:103–8.CrossRefPubMedGoogle Scholar
  55. 55.
    Zimmermann R, Gschwandtner U, Benz N, Hatz F, Schindler C, Taub E, et al. Cognitive training in Parkinson disease: cognition-specific vs nonspecific computer training. Neurology. 2014;82:1219–26.CrossRefPubMedGoogle Scholar
  56. 56.
    Dias AE, Limongi JC, Barbosa ER, Hsing WT. Voice telerehabilitation in Parkinson’s disease. Codas. 2016;28:176–81.CrossRefPubMedGoogle Scholar
  57. 57.
    Frich JC, Rae D, Roxburgh R, Miedzybrodzka ZH, Edmondson M, Pope EB, et al. Health care delivery practices in Huntington’s disease specialty clinics: an international survey. J Huntingtons Dis. 2016;5:207–13.CrossRefPubMedPubMedCentralGoogle Scholar
  58. 58.
    Borasio GD. The role of palliative care in patients with neurological diseases. Nat Rev Neurol. 2013;9:292–5.CrossRefPubMedGoogle Scholar
  59. 59.
    Ly BA, Bourgeault IL, Labonte R, Niang MN. Physicians’ perceptions on the impact of telemedicine on recruitment and retention in underserved areas: a descriptive study in Senegal. Hum Resour Health. 2017;15:67.CrossRefPubMedPubMedCentralGoogle Scholar
  60. 60.
    • Cubo E, Doumbe J, Njiengwe E, et al. A Parkinson’s disease tele-education program for health care providers in Cameroon. J Neurol Sci. 2015;357:285–7. This article describes the feasibility of a tele-education program for Parkinson’s disease in Cameroon.CrossRefPubMedGoogle Scholar
  61. 61.
    Wilkinson JR, Spindler M, Wood SM, Marcus SC, Weintraub D, Morley JF, et al. High patient satisfaction with telehealth in Parkinson disease: a randomized controlled study. Neurol Clin Pract. 2016;6:241–51.CrossRefPubMedPubMedCentralGoogle Scholar
  62. 62.
    Beck CA, Beran DB, Biglan KM, Boyd CM, Dorsey ER, Schmidt PN, et al. National randomized controlled trial of virtual house calls for Parkinson disease. Neurology. 2017;89:1152–61.CrossRefPubMedPubMedCentralGoogle Scholar
  63. 63.
    Cubo E, Mariscal N, Solano B, Becerra V, Armesto D, Calvo S, et al. Prospective study on cost-effectiveness of home-based motor assessment in Parkinson’s disease. J Telemed Telecare. 2017;23:328–38.CrossRefPubMedGoogle Scholar
  64. 64.
    Group GNDC. Global, regional, and national burden of neurological disorders during 1990-2015: a systematic analysis for the global burden of disease study 2015. Lancet Neurol. 2017;16:877–97.CrossRefGoogle Scholar
  65. 65.
    •• Korn RE, Shukla AW, Katz M, et al. Virtual visits for Parkinson disease: a multicenter noncontrolled cohort. Neurol Clin Pract. 2017;7:283–95. This article reports that Providing specialty care remotely into the homes of individuals with PD is feasible, but a one-time visit did not improve quality of life. Satisfaction with the visits was high among physicians and patients, who were interested in receiving such care in the future.CrossRefPubMedGoogle Scholar
  66. 66.
    Samii A, Ryan-Dykes P, Tsukuda RA, Zink C, Franks R, Nichol WP. Telemedicine for delivery of health care in Parkinson’s disease. J Telemed Telecare. 2006;12:16–8.CrossRefPubMedGoogle Scholar
  67. 67.
    Qiang JK, Marras C. Telemedicine in Parkinson’s disease: a patient perspective at a tertiary care Centre. Parkinsonism Relat Disord. 2015;21:525–8.CrossRefPubMedGoogle Scholar
  68. 68.
    Dorsey ER, Topol EJ. State of telehealth. N Engl J Med. 2016;375:1400.CrossRefPubMedGoogle Scholar
  69. 69.
    Mammen JR, Elson MJ, Java JJ, Beck CA, Beran DB, Biglan KM, Boyd CM, Schmidt PN, Simone R, Willis AW, Dorsey ER Patient and physician perceptions of virtual visits for Parkinson’s disease: a qualitative study. Telemed J E Health. 2017.Google Scholar
  70. 70.
    Hassan A, Dorsey ER, Goetz CG, et al. Telemedicine task force. Telemedicine for Movement Disorders: A Global Perspective (in submission).Google Scholar
  71. 71.
    Silva de Lima AL, Hahn T, Evers LJW, de Vries NM, Cohen E, Afek M, et al. Feasibility of large-scale deployment of multiple wearable sensors in Parkinson’s disease. PLoS One. 2017;12:e0189161.CrossRefPubMedPubMedCentralGoogle Scholar
  72. 72.
    Henderson EJ, Lord SR, Brodie MA, Gaunt DM, Lawrence AD, Close JCT, et al. Rivastigmine for gait stability in patients with Parkinson’s disease (ReSPonD): a randomised, double-blind, placebo-controlled, phase 2 trial. Lancet Neurol. 2016;15:249–58.CrossRefPubMedGoogle Scholar
  73. 73.
    Bot BM, Suver C, Neto EC, Kellen M, Klein A, Bare C, et al. The mPower study, Parkinson disease mobile data collected using ResearchKit. Sci Data. 2016;3:160011.CrossRefPubMedPubMedCentralGoogle Scholar
  74. 74.
    Michael J Fox Foundation (MJFF). Fox Insight Wearables: a virtual research study [online]. Available at: Accessed November 8.
  75. 75.
    Mera TO, Burack MA, Giuffrida JP. Objective motion sensor assessment highly correlated with scores of global levodopa-induced dyskinesia in Parkinson’s disease. J Parkinson's Dis. 2013;3:399–407.Google Scholar
  76. 76.
    Heldman DA, Espay AJ, LeWitt PA, Giuffrida JP. Clinician versus machine: reliability and responsiveness of motor endpoints in Parkinson’s disease. Parkinsonism Relat Disord. 2014;20:590–5.CrossRefPubMedPubMedCentralGoogle Scholar
  77. 77.
    Heldman DA, Giuffrida JP, Cubo E. Wearable sensors for advanced therapy referral in Parkinson's disease. J Parkinson's Dis. 2016;6:631–8.CrossRefGoogle Scholar
  78. 78.
    Heldman DA, Urrea-Mendoza E, Lovera LC, Schmerler DA, Garcia X, Mohammad ME, et al. App-based bradykinesia tasks for clinic and home assessment in Parkinson's disease: reliability and responsiveness. J Parkinson's Dis. 2017;7:741–7.CrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC, part of Springer Nature 2018

Authors and Affiliations

  • H. Ben-Pazi
    • 1
  • P. Browne
    • 2
    • 3
  • P. Chan
    • 4
  • E. Cubo
    • 5
  • M. Guttman
    • 6
  • A. Hassan
    • 7
  • J. Hatcher-Martin
    • 8
  • Z. Mari
    • 9
  • E. Moukheiber
    • 10
  • N. U. Okubadejo
    • 11
  • A. Shalash
    • 12
  • the International Parkinson and Movement Disorder Society Telemedicine Task Force
  1. 1.Neuropediatric unitShaare Zedek Medical CenterJerusalemIsrael
  2. 2.Neurology DepartmentUniversity Hospital GalwayGalwayIreland
  3. 3.School of MedicineNational University of Ireland GalwayGalwayIreland
  4. 4.Department of Neurobiology, Neurology and GeriatricsXuanwu Hospital of Capital Medical University BeijingBeijingChina
  5. 5.Neurology DepartmentUniversity HospitalBurgosSpain
  6. 6.University of TorontoTorontoCanada
  7. 7.Department of NeurologyMayo ClinicRochesterUSA
  8. 8.Movement Disorders Program, Department of NeurologyEmory University School of MedicineAtlantaUSA
  9. 9.Parkinson’s Disease and Movement Disorders ProgramCleveland Clinic Lou Ruvo Center for Brain HealthLas VegasUSA
  10. 10.Department of NeurologyJohns Hopkins MedicineBaltimoreUSA
  11. 11.Neurology Unit, Department of Medicine, College of MedicineUniversity of LagosLagos StateNigeria
  12. 12.Department of Neurology, Faculty of MedicineAin Shams UniversityCairoEgypt

Personalised recommendations